BICO Group(OTC) CLLKF

BICO Group AB (publ) is a global bio-convergence enterprise, operating in North America, Europe, Asia, and other international markets. The company focuses on innovative solutions in the medical devices sector, structured into two main divisions: Laboratory Solutions and Bioautomation.

Products and Services

• Advanced equipment including 3D bioprinters and hybrid microscopy systems
• Consumables such as bioinks, reagents, and 3D reconstructed human tissues
• Precision dispensing and biosensor technology for industrial customers

Growth Outlook

• Revenue of 333 million SEK in Q2 2026, showing consistent demand
• Gross profit margin of 46.8% in Q2 2026, indicating strong operational efficiency
• Expansion into new markets expected to drive future growth

Financial Highlights

• Net income of -36.9 million SEK in Q2 2026, reflecting ongoing investment in R&D
• Cash and cash equivalents of 622 million SEK as of June 2026, providing liquidity
• Current ratio of 2.42, indicating strong short-term financial health

BICO Group AB (publ) is positioned at the forefront of bio-convergence, combining biology and technology to create innovative solutions for the medical and industrial sectors. The Laboratory Solutions division caters primarily to pharmaceutical and biotechnology companies, while the Bioautomation segment focuses on industrial applications. The company has demonstrated resilience with a solid revenue stream and a robust gross profit margin, despite facing challenges reflected in its net income figures. The strong current ratio suggests that BICO Group maintains a healthy liquidity position, enabling it to navigate future growth opportunities effectively. With ongoing investments in research and development, the company is well-equipped to expand its market presence and enhance its product offerings.